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1. Introduction  
Taurine, a derivative of the sulfur-containing 
(sulfhydryl) amino acid cysteine, is the only known 
naturally occurring sulfonic acid (Brosnan and Brosnan, 
2006). It is present in high concentrations in the body, 
which provides the logic for its involvement in a variety 
of functions from osmoregulation to cardioprotection 
and from hypertension to the neurotransmitter role. All 
these actions make taurine a polyfunctional molecule, 
informing its role in maintenance of various live-forming 
processes (Gupta, 2006). Antihypertensive effects of 
taurine have been demonstrated in several experimental 
models (Fujita and Sato, 1984 and Harada et al., 2004).  
 
In-vitro studies showed that taurine relaxed 
precontracted rabbit ear artery (Franconi et al., 1982), rat 
aorta (Ristori and Verdetti, 1991) and rat mesenteric 
artery (Li et al., 1996).  
Thoracic aortic rings isolated from rats that were 
chronically given beta-alanine to deplete internal taurine 
showed enhanced contractile responses to 
norepinephrine and high potassium, and reduced 
relaxant responses to sodium nitroprusside and 
acetylcholine (Abebe and Mozaffari, 2003). Thoracic 
aortic rings isolated from rats that were chronically given 
taurine showed reduced contractile responses to 
norepinephrine and high potassium nonspecifically 
(Abebe and Mozaffari, 2000). These experiments 
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suggest that taurine plays an important role in the 
maintenance and regulation of vascular tone in normal 
and pathological situations. However, the effects of 
taurine in other vascular beds and the underlying 
mechanism(s) are not well documented yet.  
Taurine has been recognized as an antioxidant long 
time ago, scavenging both reactive oxygen and 
nitrogeneous radicals. Cyclophosphamide (CYP) is one of 
most effective chemotherapeutic agents used in  
treatment of many types of cancers (Gallagher, 2003). 
Cancer patients usually rank pneumonitis as one of the 
most distressing side effects after CYP therapy (Blossom 
et al., 1997). The mechanism of such side effects is 
possibly the generation of free radicals through CYP 
activation which may cause direct injury to epithelial cells 
of the lung. Such initial lung injury may subsequently 
increase the influx of activated inflammatory cells into 
lung parenchyma. The inflammatory cells , such as 
macrophages or polymorphonuclear cells, produce 
reactive oxygen species (ROS), and these ROS may be 
important contributors to pathogenesis of CYP-induced 
pneumonitis  (Colvin, 1982).  
The present study was undertaken to examine the 
effect of taurine on isolated pulmonary arterial rings and 
tracheal strips of rats and to investigate the possible 
mechanism(s) of its action. This was done  by evaluating 
the influence of autonomic control, arachidonic acid 
metabolites, potassium ions, and nitric oxide on the 
effect of taurine. The antioxidant effect of taurine was 
also investigated. 
 
 
2. Materials and methods 
2.1. Materials 
Adult Sprague-Dawley rats of both sexes weighing 
200-250g were used. Animals were obtained from local 
source (Faculty of Pharmacy, Mansoura University). They 
were maintained under standard conditions of 
temperature of 25˚C with regular 12h light/12h dark cycle 
and allowed free access to standard laboratory food and 
water. 
Taurine powder (Fluka Chemie,  Switzerland), 
Serotonin creatinine sulfate monohydrate (5-HT) powder 
(Fluka Chemie, Switzerland), Propranolol, (Inderal 
ampoules, 0.1% , Astrazeneca, UK), Nω-nitro-L-arginine 
methyl ester hydrochloride (L-NAME) powder (Fluka 
Chemie, Switzerland), Aminophylline, (Cidophylline 
ampoules, 250mg/10ml, Chemical Industries 
Development; CID, Egypt, under license from Schering 
AG, Germany), Amiodarone HCl, (cordarone ampoules 
150mg/3ml, Sanofi Aventis), Atropine sulphate powder 
(fine-chem. Ltd., India), Chlorpheniramine maleate, 
(Pirafene ampoules, 5mg/ml, Memphis Co. For Pharma. 
& Chemical Ind., Cairo, Egypt), Cyclophosphamide, 
(Cycram vial, 1gm white powder, EIMC Pharmaceuticals 
Co., Egypt), Indomethacin powder (PHARCO 
Pharmaceuticals, Alexandria, Egypt) and Montelukast 
powder (Merck Sharp & Dhom, California, USA). 
  
2.2. Effect of taurine on isolated pulmonary arterial 
rings and tracheal strips of rats 
 
2.2.1  Preparation of pulmonary arterial rings 
 
Rats were killed by an overdose of diethylether. The 
chest was opened along the right side of the sternum. 
The pericardium and the connective tissue between 
aorta and pulmonary artery were removed. The 
pulmonary artery was tied gently, separated and rapidly 
placed in warm physiological salt solution. The 
composition of the physiological salt solution (PSS) in 
mM/L was: NaCl, 118; KCl, 4.7; CaCl2.2H2O, 2.5; KH2PO4, 
1.2; MgSO4.7H2O, 1.2; NaHCO3, 25; and glucose, 10 (El-
Mazar et al., 1995). 
The pulmonary artery was trimmed and cut into 
rings. The rings were cleaned of connective tissue, and 
weighed. Each ring was suspended horizontally between 
two stainless steel parallel hooks, one of which was fixed 
and the other attached to isometric tension transducer 
for the measurement of isometric tension in an organ 
bath filled with 50 ml of the PSS at fixed temperature of 
37 ºC and continuously bubbled with 100% pure O2. 
The suspended pulmonary arterial rings were allowed to 
equilibrate for 30 minutes under a resting load of 3 g 
(Leff  et al., 1986) ; during that time the bath solution 
was replaced periodically every 5 minutes. 
 
2.2.2  Preparation of rat tracheal zig-zag strips 
 
 
 Rats were killed by an overdose of diethylether. 
The trachea was removed and placed in PSS, the 
composition of which in mM/L was: NaCl, 118; KCl, 4.7; 
CaCl2.2H2O, 2.5; KH2PO4, 1.2; MgSO4.7H2O, 0.62; NaHCO3, 
25; and glucose, 10 (Nials et al., 1997). The trachea was 
cleaned of extraneous tissues and examined carefully to 
locate the smooth muscle. The cartilage was cut 
longitudinally; the trachea was opened on a cork board 
and kept moist with the PSS. A sharp scalpel was used to 
cut transverse slits at equally spaced intervals first on 
one side of the preparation and then on the other side 
(Emmerson and Mackay, 1979). 
The resulting zig-zag strip was then weighed. A 
cotton thread was tied to one end of the tracheal strip 
for attachment to a fixed point in the organ bath. 
Another cotton thread was tied to the other end of the 
tracheal strip and connected to the isometric transducer. 
The strip was set up in an organ bath filled with 50 ml of 
the PSS, maintained at 36 ºC and continuously bubbled 
with 100% pure O2 (Brunn et al., 1995). The tracheal zig-
zag was allowed to equilibrate for 40 minutes under 
resting load of 1 g (Wessler et al., 1994); during that time 
the bath solution replaced periodically every 10 minutes. 
Isometric tension generated by pulmonary arterial 
and the tracheal smooth muscles was measured using a 
displacement transducer (model 50-7905, Harvard 
Apparatus LTD., South Natick, MA, USA) and recorded 
on a two-channel oscillograph (model 50-8622, Harvard 
Apparatus LTD., USA). The responsiveness of the 
pulmonary arterial rings and tracheal strips to   different  
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agents was recorded and calculated as % relaxation of 
the initial contraction. The rings and strips were 
precontracted by (2x10-4 mM) 5-HT, when the 
contraction of the isolated pulmonary arterial rings and 
tracheal strips reach the maximum, different 
concentrations of taurine (10, 30 and 100 mM) were 
added cumulatively to the organ bath.  
 
2.3.  Effect of inhibitors on the relaxation-induced by 
taurine 
 
A contraction was made by 5-HT , after the 
contraction reaches maximum, the rings and strips were 
incubated with the inhibitor for the specified time , then 
the same concentrations of taurine (10, 30 &100 mM) 
were added cumulatively.  
The following inhibitors were used: 100 μM L-NAME 
(nitric oxide synthase inhibitor) for 20 minutes (MacLean 
and McCulloch, 1998), 0.1 μM montelukast (cysteinyl 
leukotreines receptor 1 blocker) for 5 minutes (Ishimura 
et al., 2006), 1 μM chlorpheniramine (histamine H1 
receptors blocker) for 5 minutes (Gruetter et al., 1992), 
50 mM propranolol (β-adrenoceptor blocker) for 5 
minutes (Rubanyi and Vanhotte, 1985), 10 μM 
indomethacin (cyclo-oxygenase inhibitor) for 20 minutes 
(Curzen et al., 1995), 140 μM aminophylline (adenosine 
receptors antagonist) for 5 minutes (Matsuda et al., 
2000), 1 μM atropine (muscarinic receptors blocker) for 5 
minutes (Fabiani et al., 1997) and 14 μM amiodarone 
(non selective potassium channel blocker) for 5 minutes 
(Krasteva et al., 2007). 
 
2.4.  Measurement of protective effect of taurine 
against CYP-induced lung toxicity in rats 
 
Rats were divided into four experimental groups, 
each of 6 rats. The groups were treated according to the 
following schedule: 
Group I: Control group, injected i.p. with saline 
(0.001 ml/g body weight for 8 days). 
Group II: Taurine group, injected i.p. with an equal 
volume of saline while being administered 
taurine (1% in drinking water to reach a 
dose of 1 g/kg per day, orally for 8 days). 
Group III: Received CYP (150 mg/kg, i.p. on day 7). 
Group IV: Received CYP (150 mg/kg, i.p.) and taurine 
(1% in drinking water to reach a dose of 1 
g/kg per day, orally) starting 7 days before 
CYP and continuing throughout the rest of 
the experiment (24 hours). 
 
2.5.  Sampling and biochemical parameters measuring 
 
Twenty four hours after injection of CYP, animals 
were killed by overdose of ether and the lungs were 
quickly isolated , washed with saline, blotted dry on filter 
paper, weighed and then 10% (w/v) homogenates of each 
sample were made in ice cooled suitable buffer using a 
homogenizer. The lung homogenates were used for the 
determination of thiobarbituric acid reactive substances 
(TBARS), non-protein sulfhydryl compounds (NPSH), 
superoxide dismutase activity and nitric oxide. 
 
2.6.  Statistical analysis 
Data were expressed as mean ± S.E.M. (Significance 
was accepted at p<0.05).  Statistical analysis was carried 
out using paired Student’s t-test (Daniel, 1991).  
Statistical calculations were carried out using Instat-2 
computer program (GraphPad Software Inc., V2.04, San 
Diego, CA, USA).  
 
3. Results and Discussion 
 
In the present study, taurine produced a 
concentration dependent relaxation in the isolated 
tracheal strips and pulmonary arterial rings of rats 
precontracted by serotonin. The relaxing effect of 
taurine was not influenced by pretreatment with nitric 
oxide synthase inhibitor (L-NAME), cysteinyl leukotreines 
receptor 1 blocker (montelukast), H1 receptor blocker 
(chlorpheniramine), β-adrenoceptor blocker 
(propranolol), potassium channel blocker (amiodarone), 
cyclo-oxygenase inhibitor (indomethacin) or  muscarinic 
receptor blocker (atropine) (table 1 and 2). 
Several in vitro studies showed that taurine relaxes 
precontracted arteries. In rabbit ear artery, Franconi et 
al. (1982) showed that taurine produced a concentration-
dependent relaxation in the artery precontracted by 
high potassium and a slight relaxation when the artery 
precontracted by noradrenaline. On the other hand, Li 
and colleague (1996) reported that taurine selectively 
depressed the vasoconstriction induced by 
noradrenaline without significant effects on the 
contraction elicited by other substances in isolated rat 
mesenteric artery. Similarly, Ristori and Verdetti (1991) 
reported that taurine reduced the basal tone and caused 
relaxation of the precontractions induced by 
depolarization and noradrenaline in isolated rat thoracic 
aortic rings.  
In the present study, the relaxing effect of taurine 
in the pulmonary arterial rings and tracheal strips was 
significantly potentiated by preincubation with 
adenosine receptor blocker, aminophylline. Adenosine 
has been reported to produce a concentration 
dependent decrease in pulmonary arterial tension of 
precontracted pulmonary arterial rings and theophylline 
reduces the vasodilation induced by adenosine (El-
Kashef et al., 1999). In the present study, taurine induced 
relaxation of the isolated pre-contracted pulmonary 
arterial rings was significantly potentiated by 
aminophylline, an adenosine receptor blocker (figure 1).   
This observation is puzzling since, it was expected 
that blocking of adenosine receptor would certainly 
inhibit the relaxing effect of taurine rather than 
potentiating the relaxing effects. The possible 
explanation of this puzzling observation is probably the 
existence of adenosine receptor subtype that not 
respond     to   aminophylline,   a non selective adenosine  
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Table 1.    Effect of  L-NAME, montelukast, chlorpheniramine, propranolol, indomethacin,theophylline, atropine or amiodarone on taurine 
induced relaxation of precontracted isolated pulmonary arterial rings of rats. 
 
Data are represented as mean ± S.E.M.  
* Significantly different (p<0.05) compared to respective values (before treatment) using paired student's t-test 
 
 
Table 2.    Effect of L-NAME, montelukast, chlorpheniramine, propranolol, indomethacin, theophylline, atropine or amiodarone on taurine 
induced relaxation of precontracted isolated tracheal strips of rats.  
 
Groups 
Response (% relaxation) 
                          10mM                                                           30mM                                                         100mM 
Before After Before After Before After 
L-NAME 22      21.2      48      48.6     87.2      93.2      
Montelukast 18.8      19.4      45   50.2      89.6      92.2      
Chlorpheniramine 21.6      20      55.4      51      95.1      94   
Propranolol 19.8     19.2     43.8      45.8      78.8      81.2      
Indomethacin 15.8      16.4      47      49.6      92      94   
Aminophylline 17.8      25.2      * 45      57.3      * 82.2      87.2   
Atropine 14.4      15.6      43.2      48   88.6      94.6      
Amiodarone 18.4±1.435 20.4±2.358 44.8±2.853 49.6±2.135 87.4±4.366 88.2±5.333 
Data are represented as mean ± S.E.M.  
* Significantly different (p<0.05) compared to respective values (before treatment) using paired student's t-test 
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Figure 1. Effect of aminophylline (140 μM) on taurine-induced 
relaxation of isolated pulmonary arterial rings of rats. 
Data are expressed as means ± S.E.M., n=5 
* Significantly different (p<0.05) compared with 
respective values (before treatment) using paired 
Student’s t-test. 
 
receptor blocker, or it may need either higher 
concentration of the antagonist or more time to be 
blocked.   
Adenosine had been proposed as a possible 
mediator involved in the physiopathology of asthma. 
This effect of adenosine is antagonized by theophylline 
(Nieri et al., 1997). The bronchoconstrictive action of 
adenosine is mediated in part via mast cell derived 
factors such as histamine and in other part via ACh (Nieri 
et al., 1997). In the present study, taurine induced 
relaxation of the isolated precontracted tracheal strips 
was potentiated by aminophylline indicating the 
involvement of adenosine receptor in mediating the 
relaxing effect of taurine in tracheal smooth muscles 
(figure 2). Therefore, taurine produced a concentration-
dependent relaxation in the isolated tracheal strips and 
pulmonary arterial rings of rats precontracted by 
serotonin probably by direct effect on the pulmonary 
smooth muscle and induced tracheal relaxation partly via 
blocking of adenosine receptors existing in the rat 
trachea and probably by direct effect on the tracheal 
smooth muscles. 
Many studies have focused on the detoxification 
function of taurine and have demonstrated that taurine 
reacts   with    and  neutralizes ROS, which are generated 
  
 
Groups 
Response (% relaxation) 
                        10 mM                                                          30 mM                                                       100 mM 
Before After Before After Before After 
L-NAME 20.5±0.7 19.5±0.7 49.5 ±1.4 48.5     87.8     88.8     
Montelukast 19.4     19.8     42.8     43.4     74.2     78     
Chlorpheniramine 23     21.4     49.8     45.8     78.2     84.2     
Propranolol 21     22.2     44.8     46.6     84.2     85.8     
Indomethacin 20.8     27     48     47.6     79.2     80.2     
Aminophylline 17.8     43.6     * 41.6     74.6     * 74.6     89.2      * 
Atropine 20     21.4     45.6     51.6     82.6     88     
Amiodarone 22.2±1.4 23.4±1.8 49.4±3.4 49.6±3.2 85±2.5 85±1.9 
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Figure 2.   Effect of aminophylline (140 μM) on taurine-induced 
relaxation of isolated tracheal strips of rats. 
Data are expressed as means ± S.E.M., n=5 
*Significantly different (p<0.05) compared with 
respective values (before treatment) using paired 
Student’s t-test. 
 
during    an  oxidative    cell  burst.   In this study, an 
increase in lung weight index was observed after a single 
i.p. dose of CYP (150 mg/kg ) in rat compared with the 
control group. This observation is in agreement with 
Sulkowska et al., (2002) who reported that CYP caused 
edema and inflammation in lung tissues after a single i.p. 
dose in rats. This inflammation and edema after CYP 
treatment may be responsible for the increase in lung 
and liver weight indices. 
Taurine (1% in drinking water to reach a dose of 1 
g/kg per day for 8 days) did not reduce the increase in 
lung/body weight ratio induced by CYP indicating that 
taurine did not modify the inflammation produced by 
CYP (table 3). This can be explained by the study of 
Mastaloudis et al., (2004) who demonstrated that 
supplementation with vitamin E or vitamin C prevents 
oxidative damage induced by exercise but has no 
apparent effect on inflammation. Oxidative damage and 
the inflammatory response may be operating 
independently or inflammation was great enough to 
overwhelm the effects of antioxidants. Higher doses of 
taurine or any antioxidant may be required to elicit the 
anti-inflammatory effect. 
Excessive formation of lipid peroxide is considered 
to be  an indirect in vivo feasible index for free radical 
generation and in turn, for oxidative stress in the 
pathogenesis of several lung injuries, particularly those 
caused by exposure to exogenous oxidants ( Parizada et 
al., 1991; Ryrfeldt et al., 1993). Lipid peroxidation may 
give rise to several products, most of them are 
biologically active and cytotoxic. Substances that result 
from   splitting    off   the   two  C-C bonds adjacent to the  
hydroperoxy group are alkanals, typified by MDA. These 
MDAs are highly reactive compounds that, through 
reaction with protein thiols and/or cross-linking of amino 
groups of proteins, can cause considerable intracellular 
damage (Esterbauer, 1993) .  
The MDA production, an index of lipid peroxidation, 
was increased significantly in lung homogenate 
compared to control groups after CYP administration 
(table 3). This observation is in line with many reports 
that demonstrated apparent elevation in lung TBARS 
following administration of CYP (Kaya et al., 1999; 
Sulkowska et al., 2002). This increase in MDA may reflect 
the generation of ROS or FR by CYP (Manda and Bhatia, 
2003b). 
Administration of taurine to rat before CYP 
significantly reduced the increase in lung lipid peroxide 
compared to CYP group. This result is in agreement with 
Bhat et al., 1994; Gurujeyalakshmi et al., 2000 who found 
that the antineoplastic agent, bleomycin, forms an 
intracellular bleomycin Fe+2 complex that generates 
oxygen free radicals and produces pneumonitis and 
fibrotic lesions. Addition of taurine and niacin to the 
drinking water reduced the inflammatory response in 
animals treated with bleomycin . The protective effect 
was reflected in the degree of decrease of lipid 
peroxidation. Pretreatment with taurine ameliorated 
CYP induced cystitis, as indicated by a significant 
decrease in lipid peroxides and a marked restoration of 
glutathione content (Abd-Allah et al., 2004). Taurine 
supplementation reduced lipid peroxidation in plasma 
and tissues of ethanol treated rats as evidenced by 
reduction in TBARS (Pushpakiran et al., 2004). 
Reduced glutathione (GSH) is known as one of the 
endogenous antioxidants, being identified as a protector 
against the damaging effect of free radicals (El-Khatib, 
1997). Administration of CYP, in the current study, 
reduced lung content of GSH (table 3). This is in line with 
other reports that demonstrated GSH reduction or 
depletion in lung following CYP challenging in animals. 
Sulkowska et al., (2002) and Manda and Bhatia, (2003a) 
reported that, CYP is capable to reduce the level of 
tissue GSH in both mice and rats, respectively. 
Taurine led to a significant increase of lung 
glutathione when administered before CYP in 
comparison with CYP-injected group. This observation is 
in agreement with the study conducted by Venkatesan 
and Chandrakasan, (1994) which showed that 
pretreatment of rats with daily intraperitoneal injection 
of taurine plus niacin 7 days prior to and 2 days after CYP 
significantly inhibited the development of lung injury, 
prevented the alterations in lavage fluid biomarkers 
associated with inflammatory reactions, with less lipid 
peroxidation and restoration of reduced glutathione. It 
was reported that pretreatment with taurine leads to 
restoration of GSH content in rat urinary bladder treated 
with CYP (Abd-Allah et al., 2004). Additionally, taurine 
overcome lead induced oxidative stress as evidenced by 
an increase in reduced glutathione content (Gurer et al., 
2001).  
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Table 3.    Effect of cyclophosphamide(CYP, 150 mg/kg) and its combination with taurine (1%) on lung/body weight ratio , GSH , MDA , SOD 
& nitrate/nitrite levels in rat lung. 
- Data are expressed as mean ± SEM , n = 6. 
- Taurine was administered orally for 7 days before and 1 day after CYP injection. 
- Single dose of CYP was injected i.p. 
- * significantly different from control group using unpaired student,s t test (p<0.05). 
- $ significantly different from CYP group using unpaired student,s t test (p<0.05). 
 
The increase of GSH may be the mechanism of 
taurine induced relaxation of smooth muscles where 
Joris et al., (2002) showed that GSH and other thiols 
dependently decreased the tension in isolated guinea pig 
tracheas. Relaxations by GSH were paralleled with 
sevenfold increased nitrite levels in the tracheal effluent, 
suggesting an interaction between GSH and NO. 
However, preincubation with a NO scavenger did not 
reduce the relaxations by GSH or its NO adduct, S-
nitrosoglutathione (GSNO). 
Superoxide dismutase (SOD) is an enzyme which 
catalyzes the dismutation of O2
.-
 to a less toxic product 
(Fridovich, 1978) and is present in cells capable of 
aerobic metabolism (Fridovich, 1974). CYP produced no 
significant change in lung SOD (table 3), a result that 
agreed with the work of Sulkowska et al., (2002).  In 
contrast, CYP, 100 mg/kg as a single i.p. dose for 5 days in 
rats decreased lung SOD (Patel and Block, 1985). Such 
controversy could be explained in virtue of the postulate 
that the total period of drug administration and the 
dosage itself seem to regulate the activity of antioxidant 
enzymes. In the current study, pretreatment with 
taurine produce no significant change in SOD activity 
from CYP treated group. 
Nitric oxide (NO) is an endogenous mediator of 
numerous physiological processes that range from 
regulation of cardiovascular function and 
neurotransmission to antipathogenic and tumoricidal 
responses (MacMicking et al., 1997). Formation of NO 
from L-arginine is catalyzed by a diverse family of nitric 
oxide synthase (NOS) isoenzymes (Bredt et al., 1994). 
Activation of the immune system can result in 
expression of inducible NOS (iNOS) in numerous cell 
types (Marletta, 1993). Upregulation of iNOS, and the 
consequent overproduction of NO, has been implicated 
as a promoter of the severity of an array of diseases 
including cancer, stroke, diabetes, and sepsis (Wink, 
1998). As NO levels may be useful markers of 
inflammation and disease pathogenesis, it was measured 
in this study. 
In the present study, the level of nitrate/nitrite 
measured in the lung of CYP-treated group showed no 
significant change from control group and pretreatment 
with taurine did not change nitrate/nitrite level when 
compared to either control or CYP group (table 3). In 
summary, taurine showed antioxidant activity as 
evidenced by increasing the level of lung GSH and 
decreasing the lung MDA in rats pretreated by CYP.   
    
4. Conclusion 
 
Taurine relaxes precontracted rat tracheal strips 
and pulmonary arterial rings probably by direct effect on 
the smooth muscles. Also, taurine has antioxidant 
activity which may contribute to its relaxant effect. 
Taurine may be useful in protection and treatment of 
bronchial asthma. 
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